載入中
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
前收盤價
US$1.87
+US$0.18 · +10.65%
盤中時間採用ET。市場資料可能有所延遲。
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
日內區間
目前US$1.87
52週區間
目前US$1.87
盤中時間採用ET。市場資料可能有所延遲。
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
日內區間
目前US$1.87
52週區間
目前US$1.87
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
